## **Core Concept**
Rapid sequence induction (RSI) of anesthesia is an emergency procedure used to quickly secure the airway in patients who are at high risk of aspiration. The goal is to rapidly induce unconsciousness and muscle relaxation to facilitate endotracheal intubation while minimizing the time the patient's airway is unprotected.

## **Why the Correct Answer is Right**
The correct approach during RSI involves administering a rapid-acting induction agent followed by a neuromuscular blocking agent (NMBA) to facilitate quick tracheal intubation. The sequence typically involves administering the induction agent (e.g., propofol, etomidate) and immediately followed by a depolarizing neuromuscular blocker (e.g., succinylcholine) to quickly relax the muscles. This allows for swift intubation and reduces the risk of aspiration.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because it does not accurately reflect the standard practice during RSI. The specifics can vary based on the context, but generally, administering a non-depolarizing neuromuscular blocker before the induction agent or delaying the intubation would not align with RSI goals.
- **Option B:** Incorrect as it suggests administering the neuromuscular blocker before the induction agent or an inappropriate sequence that could lead to inadequate anesthesia before intubation, potentially causing patient discomfort or awareness.
- **Option C:** This option correctly outlines the typical approach for RSI, emphasizing the immediate administration of a neuromuscular blocker after the induction agent to quickly secure the airway.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in RSI is the administration of a **single dose of a rapid-acting induction agent** (like propofol or etomidate) **followed immediately by succinylcholine** to achieve rapid sequence intubation. This approach prioritizes speed and efficacy in securing the airway while minimizing the risk of gastric aspiration.

## **Correct Answer:** . Administering a rapid-acting induction agent immediately followed by a neuromuscular blocking agent.